Long-term cardiac rehabilitation program favorably influences fibrinolysis and lipid concentrations in acute myocardial infarction

Haematologica

Volumn 83, Issue 6, 1998, Pages 519-524

  Páramo, José A ^a   Olavide, Isidro ^a   Barba, Joaquín ^a   Montes, Ramón ^a   Panizo, Carlos ^a   Muñoz, Ma Carmen ^a   Rocha, Eduardo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Acute myocardial infarction; Exercise; Fibrinolysis; Lipoprotein(a); PAI 1

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE; EXERCISE TEST; FEMALE; FIBRINOLYSIS; HEART REHABILITATION; HEMATOLOGICAL PARAMETERS; HUMAN; LIPID BLOOD LEVEL; MALE; PHYSICAL ACTIVITY; TREATMENT OUTCOME;

ACUTE DISEASE; FEMALE; FIBRINOLYSIS; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; TIME FACTORS;

EID: 0031854231     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326:242-50.
2. Juhan Vague I, Collen D. On the role of coagulation and fibrinolysis in atherosclerosis. Ann Epidemiol 1992; 2:427-38.
3. Hamsten A, Eriksson P. Fibrinolysis and atherosclerosis: an update. Fibrinolysis 1995; 8 (Suppl 1):253-62.
4. Rocha E, Páramo JA. The relationship between impaired fibrinolysis and coronary heart disease: a role for PAI-1. Fibrinolysis 1994; 8:294-303.
5. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78:3114-24.
6. Juhan-Vague I, Alessi M. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost 1993; 70:138-43.
7. Páramo JA, Colucci M, Collen D, Van der Werf F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J 1985; 291:573-4.
8. Francis RB, Kawanishi D, Baruch T, Maherer P, Rahimtoola S, Feinstein DI. Impaired fibrinolysis in coronary artery disease. Am Heart J 1988; 115:776-80.
9. Hamsten A, Waldius G, Szamosi A, et al. Plasminogen activator inhibitor activity in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2:3-9.
10. ECAT Angina Pectoris Study Group. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14:8-17.
11. Streiff M, Bell WR. Exercise and hemostasis in humans. Semin Hematol 1994; 31:155-65.
12. Gris JC, Schved JF, Aguilar-Martínez P, Sánchez N. Impact of physical training on plasminogen activator inhibitor activity in sedentary men. Fibrinolysis 1990; 4 (Suppl 2):97-8.
13. Rydzewski A, Sakata K, Kobayashi A, et al. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Haemostasis 1990; 20:305-12.
14. Estellés A, Aznar J, Tormo G, Sapena P, Tormo V, España F. Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction. Thromb Res 1989; 55:203-12.
15. Lavie CJ, Milani RV, Littman AB. Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly. J Am Coll Cardiol 1993; 22:678-83.
16. Chen MF, Hsu HC, Lee YT. Effects of acute exercise on the changes of lipid profiles and peroxides, prostanoids and platelet activation in hypercholesterolemic patients before and after treatment. Prostaglandins 1994; 48:157-74.
17. Korninger C, Speiser W, Wojta J, Binder BR. Sandwich ELISA for t-PA antigen employing a monoclonal antibody. Thromb Res 1986; 41:527-35.
18. Páramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic level of tissue-type plasminogen activator and its fast-acting inhibitor. Relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemost 1985; 54:713-6.
19. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71:220-5.
20. Labeur C, Michiels G, Bury J, Uscher DC, Rosseneau M. Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin Chem 1989; 35:1380-4.
21. Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tisue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313:1557-63.
22. Schneiderman MD, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992; 79:6998-7002.
23. Speiser W, Langer W, Pschaick A, et al. Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sport program. Thromb Res 1988; 51:543-55.
24. Estellés A, Tormo G, Aznar J, España F, Tormo V. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Thromb Res 1985; 40:373-83.
25. Stratton JR, Chandler WL, Schwartz RS, et al. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83:1692-7.
26. Moxley RT, Brakeman P, Astrup T. Resting levels of fibrinolysis in blood in inactive and exercising men. J Appl Physiol 1970; 28:549-52.
27. Keber D, Stegnar M, Keber Y, Accetto B. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion. Thromb Haemost 1979; 41:745-55.
28. Williams RS, Logue EE, Lewis JL, et al. Physical conditoning augments the fibrinolytic response to venous occlusion in healthy adults. N Engl J Med 1980; 302:987-91.
29. Ferguson EW, Bernier LL, Banta GR, Yu-Yahiro J, Schoomaker EB. Effects of exercise and conditioning on clotting and fibrinolytic activity in men. J Appl Physiol 1987; 62:1416-21.
30. Schneider SH, Kim HC, Khachadurian AK, Ruderman NB. Impaired fibrinolytic response to exercise in type II diabetes: effects of exercise and physical training. Metabolism 1988; 10:924-9.
31. Bounameaux H, Righetti A, Moerloose P, Bongard O, Reber G. Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemia. Thromb Res 1992; 65:27-32.
32. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93:210-4.
33. Rocha E, Sainz R, Páramo JA, Solana JM, Fernández J, Cuesta B. The fibrinolytic system in coronary artery disease [abstract]. Thromb Haemost 1989; 62:232.
34. Marburger CF, Hambrecht TR, Niebauer J, et al. Association between lipoprotein (a) and progression of coronary artery disease in middle-aged men. Am J Cardiol 1994; 73:742-6.
35. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein (a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation 1995; 91:1403-9.
36. Boyden TW, Pamenter RW, Going SB, et al. Resistance exercise training is associated with decreases in serum low-density lipoprotein cholesterol levels in premenopausal women. Arch Intern Med 1993; 153:97-100.
37. Ponjee GA, Janssen EM, Van Wersch JW. Long-term physical exercise and lipoprotein(a) levels in a previously sedentary male and female population. Ann Clin Biochem 1995; 32:181-5.
38. Austin A, Warty V, Janosky J, Arslanian S. The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM. Diabetes Care 1993; 16:421-5.
39. Edelberg JM, Pizzo SV. Lipoprotein(a): the link between impaired fibrinolysis and atherosclerosis. Fibrinolysis 1991; 5:135-43.
40. Linheim SR, Notelovitz M, Feldman EB, Laren S, Khan FY, Lobo RA. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women. Obstet Gynecol 1994; 83:167-72.
41. Sagiv M, Goldbourt U. Influence of physical work on high density lipoprotein cholesterol: implications for the risk of coronary heart disease. Int J Sports Med 1994; 15:261-6.
42. Boman K, Hellsten G, Bruce A, Hallmans G, Nilsson TK. Endurance physical activity, diet and fibrinolysis. Atherosclerosis 1994; 106:65-74.
43. Cigolini M, Targher G, Seidell JC, et al. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. Atherosclerosis 1994; 106: 139-47.